What is the primary absorption target for the CUBE4 Treatment beam #3?

The primary absorption target for the CUBE4 Treatment beam #3 is cytochrome-c oxidase. Cytochrome-c oxidase, which is part of the mitochondrial respiratory chain, plays a crucial role in cellular respiration and energy production. The wavelengths used in the CUBE4 system are specifically selected because they are optimally absorbed by this target. When the treatment beam reaches the tissue, the energy is absorbed by cytochrome-c oxidase, facilitating increased cellular metabolism, ATP production, and promoting healing and tissue regeneration.

This principle aligns with the therapeutic effects of laser therapy, particularly in terms of enhancing cellular functions and facilitating recovery. Light therapy leveraging specific wavelengths that target cytochrome-c oxidase stands out for its efficacy in various clinical applications, thereby reinforcing the importance of this target in laser treatments.